BRWA
ITCI

B. Riley Wealth Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

B. Riley Wealth Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,500
Closed -$44K – 2052
2014
Q4 		$44K Buy
+2,500
New +$39.1K ﹤0.01% 2159
2014
Q3 		– Sell
-2,500
Closed -$42.1K – 1943
2014
Q2 		$42.1K Buy
+2,500
New +$41.3K 0.01% 1108

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

B. Riley Wealth Advisors's ITCI Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2015, closing a stake of 2,500 shares — an estimated $44K sold.

B. Riley Wealth Advisors first reported a position in ITCI in Q2 2014 and held it in 2 quarters. The position peaked at $44K in Q4 2014. 74 funds tracked by Wall St. Rank hold ITCI as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 2,500 Intra-Cellular Therapies Inc. shares in Q1 2015, an estimated $44K.
  • B. Riley Wealth Advisors first reported a position in Intra-Cellular Therapies Inc. in Q2 2014 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Intra-Cellular Therapies Inc. position peaked at $44K in Q4 2014.
  • 74 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.